Date of Conferral
2021
Degree
Doctor of Nursing Practice (DNP)
School
Nursing
Advisor
Courtney Nyange
Abstract
AbstractThe number of women suffering from opioid use disorder during pregnancy is a national epidemic. The gap in nursing practice is the lack of detoxification and medication-assisted treatment facilities that are equipped to care for this vulnerable population. The purpose of this project was to develop a clinical practice guideline (CPG) that is safe for both the fetus and the pregnant mother. Opioid dependence during pregnancy is on the rise with the nation’s current opioid epidemic. In this project, a meta-synthesis review was used to gather evidence from various sources and to develop a detox CPG that is safe for mothers and infants. An expert panel of four nurse practitioners, two psychiatrists, and two OBGYNs reviewed the CPG using the AGREE II instrument. Each area was assessed using a 7-point scale. All panelists agreed that the CPG was appropriate and required no immediate changes prior to implementation. The CPG ensures that this population is being treated with the most up-to-date treatment modalities, thus improving patient care. The potential positive social change linked to this project is reducing the number of neonatal abstinence syndrome births due to opioid use during pregnancy. A reduction has the potential to improve the mothers’ and infants’ health outcomes and also reduce mortality rates. The well-being of mothers and infants determines the health of the future generation and helps predict future health challenges for families, communities, and the health care system.
Recommended Citation
Ward, Becca, "Development of a Detox Clinical Practice Guideline for Pregnant Women Suffering from Opioid Addiction" (2021). Walden Dissertations and Doctoral Studies. 10557.
https://scholarworks.waldenu.edu/dissertations/10557
